Hematology Oncology Associates of Central New York
The purpose of this research is to evaluate instrument functionality and develop a reference range of normal data by healthy volunteers.
Inclusion Criteria: * Age 18 years or older * Able to consent to study Exclusion Criteria from entire study * Primary hemostasis diagnosis * Von Willebrand Disease * Bernard-Soulier syndrome * Glanzmann thrombasthenia * Idiopathic thrombocytopenic purpura * Drug-induced thrombocytopenia * Heparin-induced thrombocytopenia * Thrombotic thrombocytopenic purpura * Hemolytic uremic syndrome * Participant is on anticoagulant therapy * Specifically thienopyrdines \[Ticlopidine, Clopidogrel\] and GPIIb/IIIa inhibitors \[ReoPro, Aggrastat, Integrilin\] * Participant is on medicat…
Cohort B will receive one (1) 325 mg aspirin 24 hours prior to their second blood draw.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.